Jutta Deininger
Medical College of Wisconsin · 31 works · 579 citations · h-index 6
Top works
- Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms
- Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease
- Protein kinase A RII‐like (R2D2) proteins exhibit differential localization and AKAP interaction
- High-throughput mutational screen of the tyrosine kinome in chronic myelomonocytic leukemia
- Clonal chromosomal abnormalities in CD34+/CD38− hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
- Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapy
- Effects of CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induced MPD
- Supplementary Methods and Materials from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Figure 2 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Figure 5 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Methods and Materials from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Table 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Table 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Figure 3 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Figure 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Indications for BRCA1 and BRCA2 mutation testing in hereditary breast and ovarian cancer families
- Data from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Figure 5 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease
- Supplementary Figure 1 from Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease